15,644 Danaher Corporation $DHR Shares Sold by Keybank National Association OH

Keybank National Association OH lowered its holdings in Danaher Corporation (NYSE:DHR) by 4.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 301,825 shares of the conglomerate’s stock after selling 15,644 shares during the period. Keybank National Association OH’s holdings in Danaher were worth $66,869,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Main Street Group LTD purchased a new position in shares of Danaher during the first quarter valued at $25,000. N.E.W. Advisory Services LLC acquired a new position in Danaher during the second quarter valued at $25,000. Marquette Asset Management LLC raised its position in Danaher by 192.1% during the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after buying an additional 73 shares during the period. Field & Main Bank purchased a new stake in Danaher in the 2nd quarter worth about $29,000. Finally, Solstein Capital LLC purchased a new stake in Danaher in the 2nd quarter worth about $33,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Activity

In related news, CAO Christopher Bouda sold 7,598 shares of the business’s stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the completion of the sale, the chief accounting officer owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. The trade was a 45.48% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Gregory Milosevich sold 2,100 shares of the business’s stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $230.62, for a total value of $484,302.00. Following the completion of the sale, the executive vice president directly owned 22,367 shares of the company’s stock, valued at approximately $5,158,277.54. The trade was a 8.58% decrease in their position. The SEC filing for this sale provides additional information. 10.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

DHR has been the subject of a number of research reports. Morgan Stanley raised their price objective on Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research report on Monday, October 12th. TD Cowen upped their target price on Danaher from $255.00 to $270.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Barclays increased their price target on shares of Danaher from $255.00 to $260.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Guggenheim raised their price target on shares of Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a report on Thursday, October 1st. Finally, Wells Fargo & Company lowered their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Eighteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $242.91.

Danaher Price Performance

DHR opened at $236.41 on Wednesday. The stock has a market cap of $166.32 billion, a price-to-earnings ratio of 38.69, a PEG ratio of 2.95 and a beta of 0.76. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45. The stock has a fifty day moving average price of $221.10 and a 200 day moving average price of $201.55.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, October 21st. The conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same quarter in the previous year, the company posted $1.89 earnings per share. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. Analysts forecast that Danaher Corporation will post 8.59 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s payout ratio is currently 26.19%.

About Danaher

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.